✦ LIBER ✦

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III

✍ Scribed by Petra Kaufmann; John L.P. Thompson; Gilberto Levy; Richard Buchsbaum; Jeremy Shefner; Lisa S. Krivickas; Jonathan Katz; Yvonne Rollins; Richard J. Barohn; Carlayne E. Jackson; Ezgi Tiryaki; Catherine Lomen-Hoerth; Carmel Armon; Rup Tandan; Stacy A. Rudnicki; Kourosh Rezania; Robert Sufit; Alan Pestronk; Steven P. Novella; Terry Heiman-Patterson; Edward J. Kasarskis; Erik P. Pioro; Jacqueline Montes; Rachel Arbing; Darleen Vecchio; Alexandra Barsdorf; Hiroshi Mitsumoto; Bruce Levin

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 223 KB
Volume: 66
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.21743

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of chemoembolization for

Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature

✍ Claudia Tellez; Al B. Benson III; Michael T. Lyster; Mark Talamonti; John Shaw; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

an injection of a bovine collagen material with cisplatin (10 mg/mL), doxorubicin (3 mg/mL), and mitomycin C (3 mg/mL). Repeat treatments were performed at